Roivant Sciences earnings beat by $0.04, revenue fell short of estimates

Roivant Sciences (NASDAQ: ROIV) reported second-quarter earnings per share of $-0.260, surpassing analyst estimates by $0.04. However, the company's revenue of $1.44 million fell short of the consensus estimate of $2.32 million. Despite the revenue miss, Roivant Sciences' stock has shown strong performance, increasing by 21.150% in the last three months and 199.570% in the last 12 months.